Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > Great news from LBL CEO
View:
Post by MaterialWorld on Mar 12, 2020 8:51am

Great news from LBL CEO

Not only buying in and paying down debt, but paying 100 % more than current share price. That speaks volumes, shows confidence in management, and strengthens the companies balance sheet. Guy is setting the pace and direction for LBL.

Great move for share holders.    Thanks Guy.            GLTA    MW
Comment by AndrewKen on Mar 16, 2020 8:56am
"CEO Guy Cook recently settled $1 million of debt for 20 million shares at $0.05. When the conversion took place, it was a 100% premium to the stock price. Now that may be why it pulled back a bit after the initial positive reaction. We think this represents an excellent buying opportunity as $0.05 is the floor. The CEO wouldn't convert the shares at that level if he thought ...more  
Comment by MaterialWorld on Mar 16, 2020 9:23am
Good post AndrewKen. When Guy bought in at 0.05 cents, I would say he new that a SP of  at least  0.50 cents would be a good price. Don't forget that he new ( we did'nt ) that we were into a game changer with AmnioBoost Stem Cell therapy foe COVID-19. Things have changed dramatically  Every investor is going to do well with LBL and Guy Cook at the helm.  Have a great ...more  
Lattice Biologics Ltd